drugset / Trial / NCT01979003

Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion

NCT01979003

Phase 0 Completed 100 enrolled University of Arkansas
NaSingle-groupOpen-labelDiagnostic

Summary

To determine if Fluorescein systemic injection during hysterectomy procedure can be useful in revealing the depth of endometrial cancer invasion.

Timeline

Start
2014-09
Primary completion
2019-10-02
Completion
2021-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluorescein Diagnostic / imaging agent 5 ml Intravenous

Indications